SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Ionis Says Diranersen Slows Clinical Decline in Early Alzheimer’s at Two Years

The company reported a clinical finding for diranersen at the two-year mark.

IONS

Related stories